Spouting Rock Asset Management, LLC Glaukos Corp Transaction History

Spouting Rock Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$69.23 - $79.09 $38,422 - $43,894	-555 Reduced 12.42%	3,912 $294,000
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $81,155 - $127,181	-1,786 Reduced 28.56%	4,467 $318,000
Q1 2023 May 10, 2023	SELL	$43.88 - $52.48 $1,886 - $2,256	-43 Reduced 0.68%	6,253 $313,000
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $4,204 - $5,948	-103 Reduced 1.61%	6,296 $275,000
Q3 2022 Nov 08, 2022	SELL	$46.84 - $58.49 $843 - $1,052	-18 Reduced 0.28%	6,399 $341,000
Q2 2022 Aug 10, 2022	BUY	$34.86 - $63.77 $223,696 - $409,212	6,417 New	6,417 $291,000
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $245,497 - $435,974	-5,176 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $70,210 - $93,889	961 Added 22.8%	5,176 $439,000
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $296,862 - $410,625	4,215 New	4,215 $354,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.